Asia
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 24, 2020.
The diagnostic tool will use Thermo Fisher’s next-generation sequencing (NGS)-based Oncomine Dx Target Test to identify HER2 (human epidermal growth factor receptor 2) gene mutations.
Crysvita is a drug developed by Ultragenyx Pharmaceutical and Tokyo-based Kyowa Kirin Co. Ltd., a specialty pharmaceutical company.
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations.
Neurocrine Biosciences is partnering with Japan’s Takeda Pharmaceutical to develop and commercialize molecules in Takeda’s early-to-mid-stage psychiatry pipeline.
Sinovac Biotech announced positive early data from a Phase I/II clinical trial of its COVID-19 vaccine, CoronaVac. The vaccine showed both favorable immunogenicity and safety.
BioSpace takes a look at some of the most recent IPO plans from companies across the globe.
It was a fairly busy week with clinical trial updates and announcements. Here’s a look.
Biotech companies expand their footprint and capabilities in a COVID-19 world.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 12, 2020.
PRESS RELEASES